Your browser doesn't support javascript.
loading
An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates.
Saber, Haleh; Simpson, Natalie; Ricks, Tiffany K; Leighton, John K.
Afiliación
  • Saber H; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States. Electronic address: haleh.saber@fda.hhs.gov.
  • Simpson N; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.
  • Ricks TK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.
  • Leighton JK; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Hematology and Oncology Products, 10903 New Hampshire Ave, Silver Spring, MD, 20903, United States.
Regul Toxicol Pharmacol ; 107: 104429, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31325532
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / Benzodiazepinas / Inmunoconjugados Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / Benzodiazepinas / Inmunoconjugados Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Año: 2019 Tipo del documento: Article